Bath & Body Works (BBWI) Projected to Post Quarterly Earnings on Thursday

Bath & Body Works (NYSE:BBWI) is expected to release its earnings data before the market opens on Thursday, February 27th. Analysts expect Bath & Body Works to post earnings of $2.04 per share and revenue of $2.78 billion for the quarter. Bath & Body Works has set its Q4 guidance at $1.94-2.07 EPS and its Q4 2024 guidance at 1.940-2.070 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.03. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Bath & Body Works’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the company posted $0.48 earnings per share. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Stock Performance

BBWI opened at $40.15 on Thursday. The stock has a market capitalization of $8.70 billion, a price-to-earnings ratio of 9.79, a PEG ratio of 0.88 and a beta of 1.83. The company has a fifty day moving average of $37.64 and a 200 day moving average of $33.76. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 1.99%. Bath & Body Works’s payout ratio is 19.51%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on BBWI shares. Piper Sandler raised their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a research note on Monday, November 25th. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. JPMorgan Chase & Co. upgraded shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $41.00 to $47.00 in a research report on Tuesday. Finally, Argus reiterated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $43.56.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.